Mahamaya Lifesciences Limited – IPO
Mahamaya Lifesciences Limited – IPO Details
| IPO Date | November 11, 2025 to November 13, 2025 |
| Listing Date | November 18, 2025 |
| Face Value | ₹ 10 / Share |
| Price Band | ₹ 108 to ₹ 114 / Share |
| Lot Size | 1200 Shares |
| Total Issue Size | 61,78,800 shares (Aggregating up to ₹70.44 Cr) |
| Fresh Issue | 53,29,200 shares (Aggregating up to ₹60.75 Cr) |
| Offer for Sale | 5,40,000 shares of ₹10 (Aggregating up to ₹6.16 Cr) |
| Employee Discount | |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE SME |
| Share holding pre issue | 1,77,66,200 shares |
| Share holding post issue | 2,34,05,000 shares |
| Market Maker portion |
Mahamaya Lifesciences Limited Timeline (Tentative Schedule)
Mahamaya Lifesciences Limited IPO opens on November 11, 2025, and closes on November 13, 2025.
| IPO Open Date | November 11, 2025 |
| IPO Close Date | November 13, 2025 |
| Basis of Allotment | November 14, 2025 |
| Initiation of Refunds | November 17, 2025 |
| Credit of Shares to Demat | November 17, 2025 |
| Listing Date | November 18, 2025 |
| Cut-off time for UPI mandate confirmation | November 13, 2025 |
Mahamaya Lifesciences Limited IPO Lot Size
Investors can bid for a minimum of 2,400 shares and in multiples of 1,200 shares thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 2,400 | Rs.273,600 |
| Retail (Max) | 2 | 2,400 | Rs.273,600 |
| S-HNI (Min) | 3 | 3,600 | Rs.410,400 |
| S-HNI (Max) | 7 | 8,400 | Rs.957,600 |
| B-HNI (Min) | 8 | 9,600 | Rs.1,094,400 |
| HNI (Min) |
Mahamaya Lifesciences Limited IPO Promoter Holding
| Share Holding Pre Issue | 77.27% |
| Share Holding Post Issue | 56.35% |
Mahamaya Lifesciences Limited IPO Reservation
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | |
|
| Market Maker Shares Offered | |
|
| Other Shares Offered | |
|
| QIB Shares Offered | Not more than 50% |
|
| NII (HNI) Shares Offered | Not more than 15% |
|
| bNII > ₹10L | |
|
| sNII < ₹10L | |
|
| Retail Shares Offered | Not less than 35.00% |
|
| Employee Shares Offered | |
|
| Total Shares Offered | |
Mahamaya Lifesciences Limited IPO Anchor Investors Details
| Bid Date | |
| Shares Offered | |
| Anchor Portion Size (In Cr.) | |
| Anchor lock-in period end date for 50% shares (30 Days) | |
| Anchor lock-in period end date for remaining shares (90 Days) |
About Mahamaya Lifesciences Limited
Incorporated in 2002, Mahamaya Lifesciences Limited is engaged in manufacturing, registration and export of finest crop protection products and bioproducts for crop & soil health management and to help the farming community for more productivity.
The company specializes in manufacturing pesticide formulations and supplying bulk products to Indian agrochemical companies and multinational corporations (MNCs).
The company imports carefully researched molecules, registers them with the Central Insecticides Board, and markets them as technical and value-added formulations for domestic manufacturers and multinational corporations (MNCs).
The company has invested in global product registrations, with active markets in countries like the Dominican Republic, Egypt, Ethiopia, Jordan, UAE, and Turkey, offering high-quality products and data support for registrations.
Product Portfolio:
- Bulk Formulations Sales: Acetamiprid, SP Buprofezin, SC Emamectin benzoate, SG Imidacloprid, SC Paraquat Dichloride.
- Technical Sales: Acetamiprid Technical 99% Min, Atrazine Technical 95% Min, Imidacloprid Technical 95% Min, Emamectin Benzoate Technical 95% Min.
- Branded Sales (Major own branded products): MAYAMRIT GR, MAYAMRIT SL, MAYAGIBB, UCHIT EW 370
- Export Sales- Formulations: Wiper (Sulphur 80% WDG), Lancha (Pendimethalin 50% EC), Tolfen (Tolfenpyrad 15% EC), Typic (80% Sulphur WG).
Competitive Strengths:
- Experienced management team consisting of experts.
- Capability to introduce vital products for Indian Agriculture.
- Development of export opportunities of products.
- Ability to develop brands.
- Cordial relationships with suppliers of raw materials.
- Core values focused on achieving sustainability through innovative approaches.
Key Performance Indicator
The market capitalization of Mahamaya Lifesciences IPO is ₹266.82 Cr.
| KPI | Values |
|---|---|
| ROE | 34.94% |
| ROCE | 23.15% |
| Debt/Equity | 1.08 |
| RoNW | 26.19% |
| P/BV | 9.40 |
| PAT Margin (%) | 4.84% |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 7.29 | 7.01 |
| P/E (x) | 15.65 | 16.25 |
Note:
- The Pre IPO EPS is calculated based on Pre issue shareholding as on the date of RHP and the latest FY earnings as of March 31, 2025, that is available in RHP.
- The Post Issue EPS is calculated based on the Post issue shareholding and annualized FY earnings of June 30, 2025, that is available in RHP.
Objects of the Issue (Mahamaya Lifesciences Limited IPO Objectives)
Mahamaya Lifesciences Limited Contact Details
Mahamaya Lifesciences Ltd. Unit No: DPT – 033, Ground Floor, Plot No: 79 – 80, DLF Prime Tower, Block, Okhla, Phase – 1 Delhi, New Delhi, 110020 Phone: +91-1146561474 Email: [email protected] |
Mahamaya Lifesciences Limited IPO Registrar
Kfin Technologies Ltd. Phone: 04067162222, 04079611000 Email: [email protected] Website: https://ipostatus.kfintech.com/ |